Overview

Protocolized vs Discretionary Use of Opioids in Acute Pain

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
We are testing whether patients who received protocolized pain management (1 mg of IV hydromorphone followed by an additional 1 mg Intravenous (IV) hydromorphone 15 minutes later if the patients wants more) will have better pain relief and no more adverse events than patients receiving discretionary care, in which the patients receives whatever IV opioid the treating physician wants to give, in whatever dose.
Phase:
Phase 3
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Analgesics, Opioid
Hydromorphone